Aspects of early arthritis. Biological therapy in early arthritis – overtreatment or the way to go?
Open Access
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 9 (3) , 211
- https://doi.org/10.1186/ar2177
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled trialArthritis & Rheumatism, 2007
- Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Treating very early rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2006
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritisRheumatology, 2004
- Diagnostic value of high‐resolution B‐mode and doppler sonography for imaging of hand and finger joints in rheumatoid arthritisArthritis & Rheumatism, 2003
- Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomesArthritis & Rheumatism, 2002
- Factors predicting response to treatment in rheumatoid arthritis: The importance of disease durationArthritis & Rheumatism, 2000
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study.Annals of the Rheumatic Diseases, 1989